JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on July 27, 2006; DOI: 10.1124/jpet.106.105981


0022-3565/06/3192-739-748$20.00
JPET 319:739-748, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.105981v1
319/2/739    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bavadekar, S. A.
Right arrow Articles by Feller, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bavadekar, S. A.
Right arrow Articles by Feller, D. R.

CELLULAR AND MOLECULAR

Tethered Yohimbine Analogs as Selective Human {alpha}2C-Adrenergic Receptor Ligands

Supriya A. Bavadekar, Guoyi Ma, Suni M. Mustafa, Bob M. Moore, Duane D. Miller, and Dennis R. Feller

Department of Pharmacology (S.A.B., D.R.F.) and National Center for Natural Products Research (G.M., D.R.F.), School of Pharmacy, University of Mississippi, Oxford, Mississippi; and Department of Pharmaceutical Sciences (S.M.M., B.M.M., D.D.M.), University of Tennessee Health Science Center, Memphis, Tennessee

Yohimbine is a potent and relatively nonselective {alpha}2-adrenergic receptor (AR) antagonist. In an earlier report, we demonstrated that dimeric yohimbine analogs containing methylene and methylene-diglycine tethers were highly selective human {alpha}2C-AR ligands. Little work has been done to examine the role of the tether group or the absence of the second yohimbine pharmacophore on selectivity for human {alpha}2-AR subtypes. The goal of our study was to determine the binding affinities and functional subtype selectivities of a series of tethered yohimbine ligands in the absence of the second pharmacophore. The profiles of pharmacological activity for the yohimbine analogs on the three human {alpha}2-AR subtypes expressed in Chinese hamster ovary cells were examined using receptor binding and cAMP inhibition assays. All of the tethered yohimbine analogs exhibited higher binding affinities at the {alpha}2C- versus {alpha}2A- and {alpha}2B-AR subtypes. Notably, the benzyl carboxy alkyl amine and the carboxy alkyl amine analogs exhibited 43- and 1995-fold and 295- and 54-fold selectivities in binding to the {alpha}2C- versus {alpha}2A- and {alpha}2B-ARs, respectively. Data from luciferase reporter gene assays confirmed the functional antagonist activities and selectivity profiles of selected compounds from the tethered series. The data demonstrate that the second pharmacophore may not be essential to obtain {alpha}2C-AR subtype selectivity, previously observed with the dimers. Further changes in the nature of the tether will help in optimization of the structure-activity relationship to obtain potent and selective {alpha}2C-AR ligands. These compounds may be used as pharmacological probes and in the treatment of human disorders.


Received April 10, 2006; accepted July 20, 2006.

Address correspondence to: Dr. Dennis R. Feller, 303 Faser Hall, Department of Pharmacology and National Center for Natural Products Research, School of Pharmacy, The University of Mississippi, University, MS 38677. E-mail: dfeller{at}olemiss.edu







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.